{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:23:06Z","timestamp":1776684186764,"version":"3.51.2"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003592","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T19:15:12Z","timestamp":1426878912000},"page":"e0003592","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Randomized Single-Blinded Non-inferiority Trial Of 7 mg\/kg Pentamidine Isethionate Versus 4 mg\/kg Pentamidine Isethionate for Cutaneous Leishmaniaisis in Suriname"],"prefix":"10.1371","volume":"9","author":[{"given":"Ricardo V. P. F.","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masja","family":"Straetemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida D.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie O. A.","family":"Sabajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J. C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudy F. M.","family":"Lai A Fat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"ref1","first-page":"62","article-title":"Control of the leishmaniasis","volume":"949","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0074-02761994000200009","article-title":"Annotated list of <italic>phlebotominae (diptera)<\/italic> in Suriname","volume":"89","author":"AHJ Burgos","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","article-title":"Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam","volume":"41","author":"EJ Lai A Fat","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-4632.2009.03883.x","article-title":"Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname","volume":"48","author":"WF van der Meide","year":"2009","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","article-title":"Comparison between one and two injections of pentamidine isethionate, at 7 mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana","volume":"100","author":"M Roussel","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"MM Chren","year":"1996","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"Euro-Qol a new facility for the measurement of health related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/JCM.28.3.495-503.1990","article-title":"Rapid and simple method for purification of nucleic acids","volume":"28","author":"R Boom","year":"1990","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0732-8893(03)00040-3","article-title":"Diagnostic genotyping of Old and New World <italic>Leishmania<\/italic> species by PCR-RFLP","volume":"46","author":"J Marfurt","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref11","article-title":"Statistical Tables for the Design of Clinical Trials","author":"David Machin","year":"1987"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jir816","article-title":"Noninferiority of Miltefosine versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children","volume":"205","author":"Luisa Consuelo Rubiano","year":"2012","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/jid.2011.138","article-title":"Interpretation of Skindex-29 Scores: Cutoffs for Mild, Moderate and Severe Impairment of Health-Related Quality of Life","volume":"131","author":"CAC Prinsen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jama.295.10.1147","article-title":"Quality of reporting of non-inferiority and equivalence randomized trials","volume":"10","author":"AL Le Henanff","year":"2006","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jhep.2007.02.015","article-title":"Methodology of superiority vs. equivalence trials and non-inferiority trials","volume":"46","author":"E Christensen","year":"2007","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.socscimed.2012.04.038","article-title":"Cruel disease, cruel medicine: Self-treatment of cutaneous leishmaniasis with harmful chemical substances in Suriname","volume":"75","author":"S. Ramdas","year":"2012","journal-title":"Soc Sci Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3201\/eid1405.070433","article-title":"<italic>Leishmania (Leishmania) amazonensis<\/italic> infection in Suriname","volume":"14","author":"WF van der Meide","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4269\/ajtmh.2010.09-0360","article-title":"First cases of cutaneous leishmaniasis caused by Leishmania (Viannia) naiff\u00ef infection in Surinam","volume":"82","author":"PP van Thiel","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2012.11-0728","article-title":"Case Report: First Case of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis in Suriname","volume":"86","author":"Ricardo V. P. F. Hu","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/trstmh\/trt021","article-title":"Assessment of the quality of life of patients with cutaneous leishmaniasis in Belo Horizonte, Brazil, 2009\u20132010. A pilot study","volume":"107","author":"Toledo AC De Castro","year":"2013","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.0011-9059.2001.01396.x","article-title":"Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997\u20132000)","volume":"41","author":"MS Gurel","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1371\/journal.pntd.0000259","article-title":"Leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan","volume":"2","author":"M Kassi","year":"2008","journal-title":"PLOS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus, Brazil","volume":"84","author":"A Chrusiak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T02:17:12Z","timestamp":1598840232000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003592"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Buffet","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003592","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}